Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Burgundy-based biotech specializing in fibrotic and metabolic diseases posts the strongest gain in the index this Wednesday morning, following two…
The biotech company specializing in fibrotic and metabolic diseases is making slight progress this Tuesday, in a quasi-stable SBF 120. TD Cowen has re…
The timeline is tightening focus on Inventiva. The Daix-based biotech published its unaudited accounts for the first half of 2026 on September 28, 202…
The Dijon-based biotech company, specializing in fibrotic and metabolic diseases, has formalized an internal framework governing all its exchanges wit…
The Dijon biotech company specializing in fibrotic and metabolic diseases remains in a significantly deteriorated technical configuration, with a pric…
The Dijon-based biotech company specializing in fibrotic and metabolic diseases faces a challenging day, less than twenty-four hours before the public…
The Dijon-based biotech ends the session in the red, accumulating a decline of nearly 24% over the month. The move comes as first-half 2026 results ar…
The biopharmaceutical company entrusts operational management to a pharmaceutical industry executive as it approaches the results of its pivotal Phase…
On July 9, 2026, Inventiva completed the final step of its financial restructuring by issuing approximately 15.7 million new warrants to the European …
Biotech company Inventiva has appointed three independent directors to its board, effective June 30, 2026. These appointments aim to bolster expertise…
